Takeda announced Tuesday that it has voluntarily withdrawn its application to the Food and Drug Administration for its dengue vaccine, making it unclear when or if the vaccine will be licensed in ...

Takeda's new dengue vaccine, TAK-003, has received prequalification from the World Health Organization (WHO). TAK-003 is the second dengue vaccine to achieve this status. WHO has recommended the ...

Takeda has unexpectedly withdrawn its marketing application with the FDA for dengue fever vaccine TAK-003 and said it will reconsider whether it will attempt to bring it to market in the US.

Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. WHO recommends using TAK-003 in children aged 6–16 in ...

Japan's Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product.

Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says Much like COVID-19, an epidemic like dengue can be a big problem for governments, not just individuals.

American depositary receipts of Takeda Pharmaceutical Co. JP:4502 TAK rose more than 1% in the extended session Tuesday after the Japan-based company said its dengue vaccine got the recommendation ...

May 15 (Reuters) - The World Health Organization (WHO) said on Wednesday that it had cleared Takeda Pharmaceuticals' (4502.T), opens new tab dengue vaccine, giving international procurement ...

After decades of delays, the first vaccine for dengue fever was introduced seven ... spurring researchers at Japan’s Takeda Pharmaceutical Co. to redouble efforts on an alternative.

For years, Takeda has been working hard to bring the first travel vaccine for dengue fever to the market. Now, the company can breathe a sigh of relief as the program snagged an approval from the ...

India could receive the dengue vaccine as early as next year. According to a report by the Times of India, Japanese pharmaceutical giant Takeda is planning to launch its dengue vaccine ...

The World Health Organization has authorized a second dengue vaccine, aiming to protect millions worldwide against the mosquito-borne disease. The vaccine, named Qdenga, is recommended for ...